Demonstrating the value of genomic profiling for the optimization of treatment decisions in early breast cancer

Written by William Audeh MD, MS (Chief Medical Officer, Agendia, Inc.)


Introduction Breast cancer treatment planning is complex due to the nature of the disease. Genomic profiling of breast cancer has uncovered significant genomic diversity with important clinical implications for patient management. Healthcare professionals and patients need to understand the safety, benefits, risks and effectiveness of the various tests and treatments that are available, and treatment planning must be informed by the best evidence and weighted according to the specific characteristics and personal preferences of the patient. This has traditionally been done through clinical and pathological assessment, but healthcare professionals are now recognizing that revealing the genetic profile of the tumor...

To view this content, please register now for access

It's completely free